LINC00511 and melanoma: To test whether SPRY2 could rescue the inhibitory effect of SLNCR1 silencing on the activities of melanoma cells, SLNCR1 and/or SPRY2 were silenced in A375 and A875 cells and then collect their conditioned medium.